Theodore H. Stanley is Director at Insys Therapeutics, Inc. (INSY). They have made 11 open-market trades across 1 company since 2013, most recently 2016-08-16.
CIK 0001516479
5 open-market purchases totalling $274K since 2013, against 6 sales. Across 5 scored buys the stock is down 0.9% at ninety days, and 1.1 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -17.2% | -0.9% | -0.9% |
| Alpha | -11.4% | -1.1% | -1.1% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INSY | SELL | 2016-08-16 | 2016-08-16 | $18.02 | $270K | -15.3% | -24.8% | -18.8% |
| INSY | SELL | 2016-06-06 | 2016-06-06 | $16.27 | $260K | -17.7% | -10.8% | -9.6% |
| INSY | SELL | 2016-03-04 | 2016-03-04 | $18.11 | $362K | -4.3% | -2.8% | -4.5% |
| INSY | SELL | 2015-09-10 | 2015-09-14 | $37.04 | $148K | -17.2% | -0.9% | -0.9% |
| INSY | SELL | 2015-03-10 | 2015-03-10 | $60.03 | $198K | -17.2% | -0.9% | -0.9% |
| INSY | SELL | 2015-03-05 | 2015-03-06 | $60.11 | $403K | -17.2% | -0.9% | -0.9% |
| INSY | BUY | 2014-08-13 | 2014-08-15 | $33.93 | $102K | -17.2% | -0.9% | -0.9% |
| INSY | BUY | 2014-05-15 | 2014-05-19 | $21.94 | $88K | -17.2% | -0.9% | -0.9% |
| INSY | BUY | 2014-03-12 | 2014-03-13 | $72.53 | $36K | -17.2% | -0.9% | -0.9% |
| INSY | BUY | 2014-03-05 | 2014-03-06 | $75.78 | $30K | -17.2% | -0.9% | -0.9% |
| INSY | BUY | 2013-12-13 | 2013-12-13 | $36.15 | $18K | -17.2% | -0.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.